Opana and Roxicodone are both opioids prescribed for real pain, and both carry real risk the moment they’re used outside how they were prescribed.
What Each One Is
Opana (oxymorphone) is derived from morphine and is significantly more potent than Roxicodone, meaning a smaller dose can produce an equivalent effect. It comes in both immediate-release and extended-release forms, with the extended-release version lasting up to 12 hours, which is part of why it’s typically prescribed for longer-term or chronic pain.
Roxicodone (oxycodone) is derived from thebaine, a substance found in the opium poppy. It’s immediate-release only, with effects wearing off in roughly 4 to 6 hours, which means multiple daily doses for ongoing pain. It’s typically used for short-term pain, such as after surgery or an injury.
Both bind to opioid receptors in the brain and spinal cord, reducing pain while also triggering dopamine release and euphoria, which is the mechanism behind their misuse potential.
Why Potency Matters for Risk
Opana’s greater potency is the key difference when it comes to danger. A smaller dose produces a stronger effect, which makes it easier to misjudge how much is “too much,” especially if someone is used to Roxicodone’s dosing. Both carry high abuse and overdose risk, and Opana’s higher potency makes that risk even greater when misused.
How Misuse Happens
- Crushing and snorting or injecting, which bypasses Opana’s extended-release mechanism and delivers a much larger dose at once than intended.
- Combining with alcohol or benzodiazepines, which compounds respiratory depression risk significantly.
- Taking more or more often than prescribed, even without a specific intent to misuse.
Opioid use disorder can develop even with prescribed, as-directed use, which is part of why ongoing monitoring matters, not just avoiding obvious misuse.
Side Effects and Long-Term Risks
Both cause constipation, nausea, dizziness, drowsiness, and respiratory depression, the most serious and potentially fatal side effect. Long-term use is linked to liver and kidney strain, cognitive impairment, hyperalgesia (increased sensitivity to pain), and worsened depression or anxiety.
Prevention and Safer Use
Prescriber-set guidelines, urine drug tests, pill counts, prescription drug monitoring programs, patient education, and proper medication disposal all reduce risk for people taking either medication as prescribed.
Getting Help
According to the CDC, opioid overdoses remain a leading cause of death in the U.S. If use of either medication has shifted outside how it was prescribed, Greater Boston Addiction Centers offers medically supervised detox, medication-assisted treatment, and therapy. Call (877) 920-6583, or verify your insurance online.
Frequently asked questions
Which is more dangerous, Opana or Roxicodone?
Opana's higher potency makes its overdose risk greater when misused, particularly if its extended-release mechanism is bypassed by crushing. Both carry high abuse and overdose potential and should only be used exactly as prescribed.
What's the main difference between them?
Potency and formulation. Opana is more potent and available in both immediate- and extended-release forms for longer-term pain. Roxicodone is immediate-release only, shorter-acting, and typically used for short-term pain like post-surgery recovery.
How are these medications commonly misused?
Crushing and snorting or injecting them, which bypasses extended-release mechanisms and delivers the drug faster, and combining them with alcohol or benzodiazepines, which raises overdose risk significantly.
Can you become addicted even if you take it as prescribed?
Yes. Opioid use disorder can develop even with prescribed, as-directed use, which is part of why ongoing monitoring with a prescriber matters.
What treatment is available for opioid misuse?
Medically supervised detox, medication-assisted treatment, therapy such as CBT and DBT, and support groups like Narcotics Anonymous or SMART Recovery.
Keep reading
Clinically reviewed by Nikolas R. Protasenia, LMHC, LPC Last reviewed October 20, 2026. This article is for general information and isn't a substitute for advice from your own clinician.
